Abstract
Erythrocytes endure constant exposure to oxidative stress. The major oxidative stress scavenger in erythrocytes is glutathione. The rate-limiting enzyme for glutathione synthesis is glutamate–cysteine ligase, which consists of a catalytic subunit (GCLC) and a modifier subunit (GCLM). Here, we examined erythrocyte survival in GCLM-deficient (gclm−/−) mice. Erythrocytes from gclm−/− mice showed greatly reduced intracellular glutathione. Prolonged incubation resulted in complete lysis of gclm−/− erythrocytes, which could be reversed by exogenous delivery of the antioxidant Trolox. To test the importance of GCLM in vivo, mice were treated with phenylhydrazine (PHZ; 0.07 mg/g b.w.) to induce oxidative stress. Gclm−/− mice showed dramatically increased hemolysis compared with gclm+/+ controls. In addition, PHZ-treated gclm−/− mice displayed markedly larger accumulations of injured erythrocytes in the spleen than gclm+/+ mice within 24 h of treatment. Iron staining indicated precipitations of the erythrocyte-derived pigment hemosiderin in kidney tubules of gclm−/− mice and none in gclm+/+ controls. In fact, 24 h after treatment, kidney function began to diminish in gclm−/− mice as evident from increased serum creatinine and urea. Consequently, while all PHZ-treated gclm+/+ mice survived, 90% of PHZ-treated gclm−/− mice died within 5 days of treatment. In vitro, upon incubation in the absence or presence of additional oxidative stress, gclm−/− erythrocytes exposed significantly more phosphatidylserine, a cell death marker, than gclm+/+ erythrocytes, an effect at least partially due to increased cytosolic Ca2+ concentration. Under resting conditions, gclm−/− mice exhibited reticulocytosis, indicating that the enhanced erythrocyte death was offset by accelerated erythrocyte generation. GCLM is thus indispensable for erythrocyte survival, in vitro and in vivo, during oxidative stress.
Similar content being viewed by others
Main
As O2-carrying cells, erythrocytes are constantly exposed to oxidative stress and therefore maintain high intracellular concentrations of glutathione, a major scavenger of reactive oxygen species (ROS).1 Glutathione is a tripeptide (γ-glutamyl–cysteinyl–glycine) that is ubiquitously expressed.2 The first and rate-limiting enzyme for glutathione synthesis is glutamate–cysteine ligase, a heterodimer comprising a catalytic (GCLC) and a modifier (GCLM) subunit.3 Each subunit is coded by a separate gene, and even in the absence of GCLM, GCLC is still catalytically active.4 However, GCLM lowers the KM value for the substrate glutamate and raises the Ki value for GSH, thereby optimizing the conditions for glutathione synthesis.4 Whereas GCLC deficiency is embryonic lethal in mice, gclm−/− mice do not have an obvious phenotype under resting conditions, despite the fact that glutathione levels in many of their tissues are only ∼10–20% of those in wild-type mice.3, 5 In men, a common GCLM gene polymorphism that is associated with lower GCLM expression has been shown to increase the risk of myocardial infarction6 or may be linked to schizophrenia,7 although this association is discussed controversially.8 Gclm−/− mice are a valuable model to study conditions of low glutathione similar to those that are the consequence of genetic polymorphisms.4
Erythrocytes are devoid of organelles but certain stressors, among them ROS, can trigger their programmed death.9, 10, 11 ROS activates cation channels in the erythrocyte membrane, thereby allowing Ca2+ to enter the cell.11 Although the exact mechanism is not completely understood, it is known that Ca2+ triggers the translocation of membrane phosphatidylserine (PS) (a marker of cell death) from the inner leaflet to the outer leaflet.12 PS-externalizing erythrocytes may be sequestered mainly in the spleen before lysis.11, 12 Severe increases in ROS may induce rapid hemolysis, with the immediate rupture of the erythrocyte membrane and release of hemoglobin (Hb) into the serum.12 Large amounts of free serum Hb may accumulate and precipitate in the kidney tubules, thus impairing kidney function.12, 13 Control of ROS in erythrocytes is thus very important for mammalian survival.
In this study, we used gene-targeted gclm−/− mice to explore the impact of a low capacity to defend against ROS on erythrocyte survival under resting conditions and conditions of significant oxidative stress.
Results
GCLM-deficient erythrocytes undergo enhanced cell death due to low antioxidant capacity
To determine the effects of GCLM deficiency on the capacity of erythrocytes to resist ROS, we first determined the intracellular glutathione level in erythrocytes isolated from gclm−/− mice. In line with a previous report,5 the intracellular glutathione content of erythrocytes from gclm−/− mice was dramatically reduced compared with gclm+/+ mice (Figure 1a). In order to further characterize the ROS defense system in GCLM deficiency, we employed enzymatic tests to measure the activities of glutathione S-transferase, glutathione reductase, catalase and superoxide dismutase in erythrocytes from gclm+/+ and gclm−/− mice. As illustrated in Table 1, the enzymatic activities of glutathione S-transferase and catalase were significantly higher, whereas superoxide dismutase activity was significantly lower in gclm−/− red blood cells (RBCs). The activity of glutathione reductase was similar in erythrocytes from both genotypes (Table 1).
Next, we tested whether the dramatically reduced glutathione concentration affected the survival of gclm−/− erythrocytes following an extended ex vivo incubation. Whereas prolonged incubation at 37 °C without further treatment did not affect gclm+/+ erythrocytes, gclm−/− erythrocytes completely lysed (Figure 1b, upper panel). However, in the presence of the antioxidant Trolox, a derivative of vitamin E, lysis of gclm−/− erythrocytes could be completely prevented (Figure 1b, lower panel). This result demonstrates that enhanced death of gclm−/− erythrocytes was indeed due to decreased antioxidant capacity.
Phenylhydrazine treatment causes massive hemolysis in GCLM-deficient mice
To determine the importance of GCLM for erythrocyte survival in vivo, we exposed gclm−/− and gclm+/+ mice to phenylhydrazine (PHZ) at a dose of 0.07 mg/g b.w., which is commonly used to induce hemolytic anemia by generation of hydrogen peroxide.13, 14, 15 Twenty-four hours after PHZ treatment, gclm−/− mice showed several fold more hemolysis than gclm+/+ mice, as determined by measurements of free serum Hb (Figure 2a) and lactate dehydrogenase activity (Figure 2b). Moreover, gclm−/− mice lost more than twice as much weight compared with gclm+/+ mice over a 24 h period post treatment (Figure 2c). This indicates an overall decreased capacity of gclm−/− mice to deal with oxidative stress insults compared with gclm+/+ mice.
Injured erythrocytes accumulate in the spleens of GCLM-deficient mice upon treatment with PHZ
Our results so far indicate that imposing oxidative stress in vivo by PHZ treatment results in dramatically more death of gclm−/− than gclm+/+ erythrocytes. Injured erythrocytes are mainly sequestered in the spleen where they are cleared from the bloodstream.16 Thus, we performed histological analyses of the spleens at 24 h post-PHZ treatment. As expected, greater number of erythrocytes were apparent in the spleens of gclm−/− mice, as evident from hematoxylin and eosin stain (H&E) and iron staining (Figure 3a). Importantly, these cells showed significantly more externalized PS than erythrocytes in the spleens of PHZ-treated gclm+/+ mice, underlining enhanced erythrocyte death in gclm−/− mice following induction of oxidative stress (Figure 3b). These data indicate that mice lacking GCLM suffer from increased erythrocyte damage upon oxidative stress with accumulation of the injured erythrocytes in the spleens of gclm−/− mice.
Hb precipitates in the kidney tubules of GCLM-deficient mice upon treatment with PHZ
Upon treatment with PHZ, free serum Hb (Figure 2a) was the consequence of severe oxidative damage to erythrocytes, leading to the immediate destruction of cellular integrity and release of Hb before the injured cell could be cleared from the circulation. Free serum Hb is filtered through the glomeruli of the kidney17 and may accumulate and precipitate in renal tubules, thus reducing kidney function.13, 18 We therefore analyzed the kidneys from gclm+/ and gclm−/− mice at 24 h post-PHZ treatment. In line with dramatically more hemolysis in gclm−/− mice (Figure 2a), H&E and iron stainings revealed significant hemosiderin in the renal tubules of PHZ-treated gclm−/− mice and virtually none in the tubules of PHZ-treated gclm+/+ mice (Figure 4a). To determine whether kidney function began to be affected by Hb precipitations in PHZ-treated gclm−/− mice, we determined serum creatinine and urea levels at 24 h post-PHZ treatment. As expected, serum creatinine and urea levels were already elevated 24 h after induction of hemolysis in gclm−/− mice, confirming impairment of their renal function at this time point (Figure 4b). During the course of the experiment, gclm+/+ mice were able to recover from the oxidative stress insult and survived. Strikingly, 11/12 gclm−/− mice died within 5 days of PHZ treatment (Figure 5).
Hemolysis is triggered in GCLM-deficient mice also upon treatment with low-dose PHZ
In order to study the antioxidant response under conditions of a lower oxidative stress insult, we performed a test with low-dose PHZ (0.014 mg/g b.w.). Before injection of PHZ at this dose, the concentration of free Hb in serum from gclm+/+ and gclm−/− mice, which is indicative of hemolysis, was low and not significantly different between the genotypes (Figure 6a). Twenty-four hours after injection, the concentration of free Hb remained unchanged in gclm+/+ mice but was significantly elevated in gclm−/− mice (Figure 6a). Next, we characterized the redox status of the erythrocytes by measuring the ratio of the erythrocyte GSH concentration over the GSSG concentration. Before PHZ treatment, the ratio tended to be lower in erythrocytes from gclm+/+ mice compared with gclm−/− erythrocytes (Figure 6b). PHZ treatment tended to reduce the ratio in erythrocytes from both genotypes (Figure 6b). The levels of both GSH and GSSG were lower in gclm−/− erythrocytes before and after PHZ treatment compared with gclm+/+ erythrocytes. However, PHZ treatment significantly reduced GSH levels only in gclm−/− erythrocytes (Figure 6b). In contrast to PHZ at high dose, all gclm+/+ (n=4) and gclm−/− mice (n=4) survived the experiment for at least 1 week. Our in vivo data clearly indicate massive hemolysis in gclm−/− mice subjected to both high- and low-oxidative stress insults.
GCLM-deficient erythrocytes are more prone to Ca2+-dependent suicidal cell death ex vivo
In order to elucidate whether suicidal erythrocyte death is involved as a consequence of the higher susceptibility of gclm−/− erythrocytes to ROS-induced cell damage, the percentage of erythrocytes exposing membrane PS was measured. Significantly more erythrocytes from gclm−/− mice compared with gclm+/+ mice externalized PS at their cell surface although the total percentage of PS-exposing erythrocytes remained low in both genotypes (Figure 7a). This result indicates slightly enhanced cell death of gclm−/− erythrocytes, presumably as the consequence of lower antioxidant capacity.
To explore the capability of gclm−/− and gclm+/+ erythrocytes to resist additional oxidative stress in vitro, we incubated the cells for 30 min ex vivo at 37 °C in physiological solution. We found that merely incubating untreated gclm−/− erythrocytes resulted in a higher percentage of PS-externalizing cells than parallel incubation of gclm+/+ erythrocytes (Figure 7b). Moreover, when gclm−/− erythrocytes were subjected to additional ROS in the form of a 30 min incubation with 0.3 mM tert-butyl hydroperoxide (TBOOH) at 37 °C, again significantly more PS exposure occurred in gclm−/− than in gclm+/+ erythrocytes (Figures 7b and c), pointing to a reduced resistance of gclm−/− erythrocytes to oxidative stress. Oxidative stress-mediated erythrocyte death with subsequent PS externalization has been shown to be dependent on an increase in the cytosolic Ca2+ concentration.11 Hence, we estimated the cytosolic Ca2+ concentration of gclm−/− and gclm+/+ erythrocytes using Fluo3 fluorescence in FACS analysis. Consistent with their enhanced susceptibility to death, gclm−/− erythrocytes incubated for 30 min in the absence of treatment indeed displayed more Fluo3 fluorescence than gclm+/+ erythrocytes, indicating elevated cytosolic Ca2+ concentration (Figure 7d).
To specify the role of ROS for the erythrocyte Ca2+ concentration, we incubated the erythrocytes at 37 °C without and with Trolox for 4–8 h (gclm−/− erythrocytes start to lyse typically after a 4–8 h incubation with some variability) and quantified intracellular Ca2+ using Fluo3 before complete lysis of gclm−/− erythrocytes. We found that the normalized Fluo3 fluorescence intensity (as a measure of intracellular Ca2+) was significantly higher in gclm−/− erythrocytes compared with gclm+/+ erythrocytes (Figure 7e). Incubation with 250 μM Trolox significantly reduced Fluo3 fluorescence in gclm−/− erythrocytes (Figure 7e). In order to study the significance of Ca2+ for PS exposure, we carried out incubations without or with Trolox in the presence and absence of extracellular Ca2+ and determined the percentage of PS-exposing cells before complete lysis of gclm−/− erythrocytes. After a 4–8 h incubation at 37 °C, significantly more gclm−/− erythrocytes exposed PS in the presence of extracellular Ca2+ (Figure 7f). Addition of 250 μM Trolox significantly reduced the percentage of PS-exposing gclm−/− erythrocytes. Importantly, the absence of extracellular Ca2+ was similarly capable of blunting PS exposure of gclm−/− erythrocytes (Figure 7f). In both the absence of extracellular Ca2+ and the presence of 250 μM Trolox, PS exposure was minimal in gclm−/− erythrocytes (Figure 7f).
GCLM-deficient mice ramp up their generation of erythrocytes
In order to study whether the greater susceptibility of gclm−/− erythrocytes to death in vitro was mimicked in vivo, we analyzed blood counts from wild-type and knockout mice without any further treatment. Indeed, blood samples from gclm−/− mice contained marginally but significantly more reticulocytes than samples from gclm+/+ mice (Figure 8a). Surprisingly, under resting conditions without additional oxidative stress, gclm−/− mice were evidently able to balance the elevated death rate of their erythrocytes with marginally enhanced reticulocyte generation, as their overall erythrocyte numbers and properties were unchanged (Figure 8b).
Our ex vivo examinations showed that the enhanced death of gclm−/− erythrocytes was due to ROS because their lysis could be inhibited by Trolox. In vivo, however, the greater susceptibility of gclm−/− erythrocytes to hemolysis did not translate into anemia as long as the mice are not exposed to additional oxidative stress. Rather, under resting conditions without additional oxidative stress, the mutant animals were able to survive by slightly ramping up their generation of new erythrocytes.
Discussion
The present study explored for the first time the role of GCLM deficiency on erythrocyte survival, in vitro and in vivo, under both conditions of normal oxidative stress and conditions of increased ROS.
Gclm−/− mice are an important model of a continuously increased oxidative stress environment due to decreased glutathione production.4 Although massively depleted of glutathione, the major antioxidant in most tissues, gclm−/− mice are seemingly healthy and normal.3, 4, 5 In line with previous reports, we found that the glutathione concentration of erythrocytes from gclm−/− mice was <10% of the concentration of erythrocytes from gclm+/+ mice.3, 5 Glutathione is a major antioxidant of erythrocytes and reduces their considerable oxidative burden, which arises from their role as O2-transporting cells.19
When erythrocytes are exposed to ROS to an extent that exceeds their ROS-scavenging capacity, they may execute a program of suicidal cell death or eryptosis, which ultimately results in externalization of membrane PS.11 Erythrocytes express Ca2+-permeable cation channels, which are activated by oxidative stress.20 The Ca2+ entry through those channels increases cytosolic Ca2+ activity, leading to triggering of cell membrane scrambling.11 Moreover, Ca2+ activates Ca2+-sensitive K+ channels with subsequent hyperpolarization, exit of Cl- with osmotically obliged water and thus cell shrinkage.21 Cell membrane scrambling and cell shrinkage are hallmarks of eryptosis, the suicidal death of erythrocytes.12 The oxidant-sensitive Ca2+-permeable cation channels are in addition permeable to Na+,20 thus allowing the entry of Na+, which eventually leads to cell swelling and hemolysis. It should be noted, however, that live cells may also expose some PS at the surface, especially under conditions triggering increases in cytosolic Ca2+ concentration.
A 30 min ex vivo incubation of gclm−/− erythrocytes in a physiological solution resulted in significantly more PS exposure than the respective incubation of gclm+/+ erythrocytes, emphasizing the minimal ROS-scavenging capacity of gclm−/− erythrocytes. Under conditions of additional oxidative stress, the difference between gclm−/− and gclm+/+ erythrocytes in PS externalization became even larger (Figure 7b). Oxidative stress has been shown to induce erythrocyte PS exposure through an increase in the cytosolic Ca2+ concentration.11 Consistent with augmented PS externalization, gclm−/− erythrocytes indeed exhibited increased cytosolic Ca2+ concentration as evident from increased Fluo3 fluorescence. The elevated cytosolic Ca2+ of gclm−/− erythrocytes was at least in part the consequence of ROS, as Trolox did not only prevent erythrocyte lysis but also decreased the cytosolic Ca2+ concentration of gclm−/− erythrocytes. Moreover, PS exposure of gclm−/− erythrocytes was Ca2+-dependent, as incubation for an extended period in Ca2+-free solution, not long enough to cause complete gclm−/− erythrocyte lysis, significantly attenuated annexin V-binding.
In vivo, erythrocyte PS externalization is considered an ‘eat-me’ signal, which may be recognized by macrophages by their PS receptors.22 Thus, PS-exposing erythrocytes are normally rapidly cleared from the circulation before they lyse and release Hb.12, 23 In the case of an ex vivo incubation (in the absence of macrophages), however, gclm−/− erythrocytes lysed, as the oxidative damage obviously became too detrimental to maintain cellular integrity. Importantly, cell death of gclm−/− erythrocytes was indeed solely due to increased ROS levels as the antioxidant Trolox fully prevented their lysis.
When stained directly after blood collection, erythrocytes from gclm−/− mice externalized marginally more PS, indicating slightly enhanced erythrocyte death also in vivo. Despite their very low antioxidant capacity, however, the total percentage of PS-exposing erythrocytes remained remarkably low in gclm−/− mice. Consistent with a low percentage of PS-externalizing erythrocyte, RBC numbers and properties were not different in unstressed gclm−/− and gclm+/+ mice. Only a small but significant increase in reticulocytosis in gclm−/− mice may indicate that formation of new erythrocytes was mildly ramped up to fully compensate for a slightly increased erythrocyte death rate. This result may indicate slightly increased erythrocyte turnover in unstressed mice. In other words, oxidative stress was too low to cause overt anemia of gclm−/− mice in the absence of additional stressors. In addition, apart from glutathione, other antioxidant mechanisms are expressed in erythrocytes, which protect from oxidative damage even in glutathione deficiency.24 Among those are superoxide dismutase and catalase.25 We found increased catalase and decreased superoxide dismutase activity in RBCs from gclm−/− mice. The operation of those additional mechanisms apparently also ensured survival of gclm−/− erythrocytes in animals not exposed to additional oxidative stress. It has been shown that erythrocyte catalase, but not superoxide dismutase, protects other cells from oxidative damage.26 It is intriguing to speculate that increased catalase activity in gclm−/− erythrocytes is a compensatory mechanism to protect not only the RBCs itself but also other cells in the organism from the consequences of glutathione deficiency. Enhanced activity of glutathione S-transferase may be another strategy to protect gclm−/− RBCs from cell death in glutathione deficiency, as erythrocyte glutathione S-transferase deficiency has been linked to hemolytic anemia.27
When we subjected the mice to additional oxidative stress in the form of a single PHZ injection (0.07 mg/g b.w.), the residual antioxidant capacity was immediately insufficient to alleviate ROS-induced damage of gclm−/− erythrocytes as apparent from a sixfold higher free serum Hb concentration in gclm−/− mice. Consequently, Hb and hemosiderin accumulation occurred in the renal tubules of gclm−/− mice 24 h after treatment. This coincided with a decline in kidney function of gclm+/+ mice, as documented by increased serum creatinine and urea. Injured erythrocytes that do not immediately lyse due to oxidative damage accumulate in the spleen. Again, we observed more sequestered erythrocytes and, among those, more PS-externalizing cells in the spleens of gclm−/− mice than in those of gclm+/+ mice. This result again demonstrates a strikingly more massive destruction of gclm−/− erythrocytes compared with gclm+/+ erythrocytes.
All gclm+/+ mice fully recovered from PHZ (0.07 mg/g b.w.)-induced oxidative damage. In contrast, more than 90% of gclm−/− mice died within 5 days after treatment, indicating that finally fatal erythrocyte death was the inevitable consequence of glutathione deficiency under conditions of increased oxidative stress. When subjected to low-dose PHZ treatment (0.014 mg/g b.w.), no obvious hemolysis was observed in gclm+/+ mice. Gclm−/− mice again suffered from hemolysis, albeit milder, and that did not affect their survival.
Erythrocytes are the most abundant cell type in the mammalian body. As circulating cells, they provide antioxidant defense capacity also to other organs and tissues.24 Accordingly, they have been considered as ‘mobile free-radical scavengers’.24 When severely damaged or fully lysed upon PHZ treatment, gclm−/− erythrocytes failed to provide protection from oxidative damage also to other organs, a mechanism likely to contribute to the fatal outcome in GCLM deficiency.
Apart from human GCLM polymorphisms that lead to lower glutathione levels,6, 7 glucose-6-phosphate dehydrogenase deficiency results in lower resistance of erythrocytes to oxidative stress, as it impairs the regeneration of reduced GSH.28 Glucose-6-phosphate dehydrogenase deficiency affects 400 million people worldwide and is one of the most common inherited diseases.28 With striking similarity to gclm−/− mice, humans with glucose-6-phosphate dehydrogenase deficiency are often asymptomatic as long as they are unstressed.28 When exposed to additional oxidative stress such as in the form of fava beans they also develop hemolytic anemia.28 In vitro oxidative stress increases PS exposure to a significantly larger extent in glucose-6-phosphate dehydrogenase-deficient erythrocytes than in normal erythrocytes.29 Upon exposure to PHZ, gclm−/− mice apparently developed those severe symptoms which people with severe glucose-6-phosphate deficiency would be likely to show in a similar situation.
In summary, our data demonstrate that low erythrocyte glutathione levels due to GCLM deficiency are well tolerated by mice housed under resting conditions where oxidative stress is minimal. However, when ROS accumulations are high, mice with GCLM deficiency undergo massive hemolysis that has a fatal outcome. Thus, in a real world filled with oxidative insults, GCLM is essential for mammalian survival.
Materials and Methods
Mice
GCLM-deficient (gclm−/−) and wild-type (gclm+/+) mice (8–16-week-old males) were described previously5 and housed in the animal facility of the Princess Margaret Hospital (Toronto, Ontario, Canada) under standard conditions. For induction of ROS in vivo, mice received one i.p. injection of 0.07 mg/g b.w. (high-dose test) or 0.014 mg/g b.w. (low-dose test) PHZ (Sigma-Aldrich, Oakville, Ontario, Canada). Animal experiments were approved by the Animal Care and Use Committee of the University Health Network (Toronto, Ontario, Canada).
Erythrocytes and serum
Under light anesthesia with isoflurane, blood was drained from the retro-orbital plexus of the mice with heparinized capillaries and collected in heparin-coated tubes for erythrocyte analysis or in serum tubes for serum analysis (BD Biosciences, Mississauga, ON, Canada).
ELISA
To measure the intracellular glutathione concentration in erythrocytes, erythrocytes from 60 μl full blood were analyzed. The erythrocytes were lysed in water, the lysate was deproteinated and the glutathione concentration was measured using the Glutathione Assay Kit (Cayman Chemicals, Ann Arbor, MI, USA) or using the Bioxytech GSH/GSSG-412 kit (Percpio Biosciences, Burlingame, CA, USA) according to the provided manual. The concentration of free serum Hb was measured using an ELISA Kit (Kamiya, Seattle, WA, USA). The erythrocyte activities of glutathione S-transferase, glutathione reductase, catalase and superoxide dismutase were measured with enzyme assay kits from Cayman Chemicals. To ascertain comparability between the genotypes, erythrocytes were pelleted and the same volume of erythrocyte pellet used for the assays.
Flow cytometry
To determine PS exposure, erythrocytes were stained with Annexin-V-FITC (1 : 1000; BD Biosciences) in incubation buffer (125 mM NaCl, 5 mM KCl, 5 mM glucose, 32 mM HEPES, 1 mM Mg2SO4, 1 mM CaCl2, pH 7.4) plus an additional 4 mM CaCl2 for 15 min at 37 °C and analyzed on a FACS Calibur (BD Biosciences) in fluorescence channel FL-1. To estimate the intracellular Ca2+ concentration erythrocytes were stained with Fluo3/AM (Invitrogen, Burlington, Ontario, Canada; 1 : 1000 in incubation buffer) for 15 min at 37 °C. Reticulocyte numbers were determined with RETIC-count (BD Biosciences) according to the provided protocol. For some experiments, erythrocytes from 4 μl blood were incubated for 30 min—12 h (as indicated) at 37 °C in 1000 μl incubation buffer with or without 0.3 mM TBOOH (Sigma-Aldrich), an oxidative stress stimulus; or with or without 250 μM Trolox (Roche, Mannheim, Germany), an antioxidant derived from vitamin E. In Ca2+-free incubation buffer, 1 mM CaCl2 was substituted for 1 mM EGTA.
Blood count and chemistry
Blood cell counts, measurements of lactate dehydrogenase activity, and determinations of serum creatinine and urea levels were performed according to veterinary standards by IDEXX (Markham, Ontario, Canada).
Histology
Mouse kidneys and spleens were formalin fixed (48 h, 4 °C) and paraffin embedded. Sections of paraffin-embedded tissues were stained with H&E or Prussian Blue to detect iron according to standard protocols.
Statistics
Data are expressed as arithmetic means±S.E.M., and statistical analyses were performed using Student’s t-test unless otherwise stated. P<0.05 was considered statistically significant.
Abbreviations
- GCLC:
-
glutamate–cysteine ligase catalytic subunit
- GCLM:
-
glutamate–cysteine ligase regulatory subunit
- GSH:
-
glutathione (reduced)
- GSSG:
-
glutathione (oxidized)
- H&E:
-
hematoxylin and eosin stain
- Hb:
-
hemoglobin
- PHZ:
-
phenylhydrazine
- PS:
-
phosphatidylserine
- RBC:
-
red blood cell
- ROS:
-
reactive oxygen species
- TBOOH:
-
tert-butyl hydroperoxide
References
Beutler E, Moroose R, Kramer L, Gelbart T, Forman L . Gamma-glutamylcysteine synthetase deficiency and hemolytic anemia. Blood 1990; 75: 271–273.
Pastore A, Federici G, Bertini E, Piemonte F . Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 2003; 333: 19–39.
Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, Dalton TP . Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(−/−) knockout mouse. Novel model system for a severely compromised oxidative stress response. J Biol Chem 2002; 277: 49446–49452.
Cole TB, Giordano G, Co AL, Mohar I, Kavanagh TJ, Costa LG . Behavioral characterization of GCLM-knockout mice, a model for enhanced susceptibility to oxidative stress. J Toxicol 2011; 2011: 157687.
McConnachie LA, Mohar I, Hudson FN, Ware CB, Ladiges WC, Fernandez C et al. Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice. Toxicol Sci 2007; 99: 628–636.
Nakamura S, Kugiyama K, Sugiyama S, Miyamoto S, Koide S, Fukushima H et al. Polymorphism in the 5'-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 2002; 105: 2968–2973.
Tosic M, Ott J, Barral S, Bovet P, Deppen P, Gheorghita F et al. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 2006; 79: 586–592.
Hanzawa R, Ohnuma T, Nagai Y, Shibata N, Maeshima H, Baba H et al. No association between glutathione-synthesis-related genes and Japanese schizophrenia. Psychiatry Clin Neurosci 2011; 65: 39–46.
Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP et al. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 2001; 8: 1143–1156.
Sarang Z, Madi A, Koy C, Varga S, Glocker MO, Ucker DS et al. Tissue transglutaminase (TG2) facilitates phosphatidylserine exposure and calpain activity in calcium-induced death of erythrocytes. Cell Death Differ 2007; 14: 1842–1844.
Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F et al. Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003; 10: 249–256.
Foller M, Huber SM, Lang F . Erythrocyte programmed cell death. IUBMB Life 2008; 60: 661–668.
Lim SK, Kim H, Lim SK, bin AA, Lim YK, Wang Y et al. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 1998; 92: 1870–1877.
Hodges VM, Winter PC, Lappin TR . Erythroblasts from friend virus infected- and phenylhydrazine-treated mice accurately model erythroid differentiation. Br J Haematol 1999; 106: 325–334.
Hirschler-Laszkiewicz I, Zhang W, Keefer K, Conrad K, Tong Q, Chen SJ et al. Trpc2 depletion protects red blood cells from oxidative stress-induced hemolysis. Exp Hematol 2012; 40: 71–83.
Safeukui I, Buffet PA, Deplaine G, Perrot S, Brousse V, Ndour A et al. Quantitative assessment of sensing and sequestration of spherocytic erythrocytes by the human spleen. Blood 2012; 120: 424–430.
Bunn HF, Esham WT, Bull RW . The renal handling of hemoglobin. I. Glomerular filtration. J Exp Med 1969; 129: 909–923.
Zager RA . Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996; 49: 314–326.
Wu G, Fang YZ, Yang S, Lupton JR, Turner ND . Glutathione metabolism and its implications for health. J Nutr 2004; 134: 489–492.
Duranton C, Huber SM, Lang F . Oxidation induces a Cl(-)-dependent cation conductance in human red blood cells. J Physiol 2002; 539: 847–855.
Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM . Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003; 285: C1553–C1560.
Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM . A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000; 405: 85–90.
Boas FE, Forman L, Beutler E . Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci USA 1998; 95: 3077–3081.
Siems WG, Sommerburg O, Grune T . Erythrocyte free radical and energy metabolism. Clin Nephrol 2000; 53: S9–17.
Ginsburg H, Atamna H . The redox status of malaria-infected erythrocytes: an overview with an emphasis on unresolved problems. Parasite 1994; 1: 5–13.
Agar NS, Sadrzadeh SM, Hallaway PE, Eaton JW . Erythrocyte catalase. A somatic oxidant defense? J Clin Invest 1986; 77: 319–321.
Beutler E, Dunning D, Dabe IB, Forman L . Erythrocyte glutathione S-transferase deficiency and hemolytic anemia. Blood 1988; 72: 73–77.
Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E . The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 2009; 42: 267–278.
Lang KS, Roll B, Myssina S, Schittenhelm M, Scheel-Walter HG, Kanz L et al. Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem 2002; 12: 365–372.
Acknowledgements
We thank Dr. B Hershenfield for technical support and Dr. M Saunders for scientific editing. M.F. was supported by a stipend from Deutscher Akademischer Austauschdienst (DAAD) and by the Deutsche Forschungsgemeinschaft (DFG FO 695/1-1).
Author Contributions
MF, ISH, FL and TWM designed the research. MF, ISH, AE and RJ performed the experiments. TJK provided gclm−/− mice and edited the manuscript. MF, FL and TWM wrote the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by G Melino
Rights and permissions
About this article
Cite this article
Föller, M., Harris, I., Elia, A. et al. Functional significance of glutamate–cysteine ligase modifier for erythrocyte survival in vitro and in vivo. Cell Death Differ 20, 1350–1358 (2013). https://doi.org/10.1038/cdd.2013.70
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cdd.2013.70
Keywords
This article is cited by
-
Low-dose and repeated exposure to fluoxetine leads to eryptosis and hematological disorder in Wistar rats
Comparative Clinical Pathology (2023)
-
Blunted apoptosis of erythrocytes in mice deficient in the heterotrimeric G-protein subunit Gαi2
Scientific Reports (2016)
-
Park7 interacts with p47phox to direct NADPH oxidase-dependent ROS production and protect against sepsis
Cell Research (2015)